Buccoadhesive gels of glibenclamide: A means for achieving enhanced bioavailability

Drug Delivery

Volumn 16, Issue 7, 2009, Pages 405-415

  Philip, A K ^a   Srivastava, M ^a   Pathak, K ^a  

^a Rajiv Academy for Pharmacy ^*  (India)

Author keywords

In vitro permeation

Indexed keywords

CARBOMER; GLIBENCLAMIDE; GLUCOSE; HYDROXY PROPYL METHYL CELLULOSE; PENETRATION ENHANCING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CHEEK MUCOSA; CONTROLLED STUDY; DIFFUSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG PENETRATION; DRUG RELEASE; EVALUATION; GEL; GLUCOSE BLOOD LEVEL; HYDRATION; HYPERGLYCEMIA; HYPOGLYCEMIA; MAXIMUM PLASMA CONCENTRATION; MOLECULAR MODEL; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; SWELLING; TABLET; TIME TO MAXIMUM PLASMA CONCENTRATION; VISCOSITY;

ADHESIVES; ADMINISTRATION, BUCCAL; ANIMALS; BIOLOGICAL AVAILABILITY; FEMALE; GELS; GLYBURIDE; MALE; MOUTH MUCOSA; RABBITS;

EID: 70449129018     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540903126314     Document Type: Article

References (25)

1. Agarwal, V., Mishra, B. (1999). Design development and pharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev Ind Pharm. 25, 701-709
2. Alur, H.H., Johnston, T.P., Mitra, A.K. (2001). Peptides and proteins: buccal absorption. In: Swarbrick, J., Boylan, J.C., eds. Encyclopedia of pharmaceutical technology. New York: Dekker, 206.
3. Alur, H.H., Pather, I.S., Mitra, K.A., Johnston, P.T. (1999). Transmucosal sustained-delivery of chlorpheniramine maleate in rabbits using a novel, natural mucoadhesive gum as an excipients in buccal tablets. Int J Pharm. 188, 1-10.
4. Attia, M.A., El-Gibaly, I., Shaltout, S.E., Fetih, G.N. (2004). Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels. Int J Pharm. 276, 11-28.
5. Davis, S.N., Granner, D.K. (1996). Insulin, oral hypoglycemic agents, and the pharmacotherapy of the endocrine pancreas. In: Hardman, J.G., Limbird, L.E., eds. The pharmacological basis of therapeutics. New York: McGraw-Hill, 1487-1517
6. Desai, S.J., Singh, P., Simonelli, A.P., Higuchi, W.I. (1966). Investigation of factors influencing release of solid drug dispersed in wax matrices. III. Quantitative studies involving polyethylene plastic matrix. J Pharm Sci. 55, 1230-1234
7. Doijad, R.C., Manvi, F.V., Rao, V.S.N.M., Patel, P.S. (2006). Buccoadhesive drug delivery system of isosorbide dinitrate: formulation and evaluation. Ind J Pharm Sci., 68, 744-748
8. Florey, K. (2005). Analytical profile of drug substances. 1st Ed. New Delhi: Elsevier India, 338.
9. Higuchi, T. (1963). Mechanism of sustained action medication, theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 52, 1145-1149
10. Hixson, A.W., Crowell, J.H. (1931). Dependence of reaction velocity upon surface and agitation: I-theoretical consideration. Ind Eng Chem. 23, 923-931
11. Kataria, U., Dwivedi, J., Kar, M. (2007). Buccal route for systemic drug delivery. Ind Pharm. 6, 13-20.
12. Korsmeyer, R.W., Gurny, R., Doelker, E.M., Buri, P., Peppas, N.A. (1983). Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 15, 25-35.
13. McElnay, J.C., Hughes, C.M. (2002). Drug delivery- buccal route. In: Swarbrick, J., Boylan, J.C., eds. Encyclopedia of pharmaceutical technology. New York: Dekker, 800-809
14. Mohammadi-Samani, S., Bahri-Najafi, R., Yousefi, G. (2005). Formulation and in-vitro evaluation of prednisolone buccoadhesive tablets. Il Farm. 60, 339-344
15. Mohammed, F.A., Khedr, H. (2003). Preparation and in vitro/in vivo evaluation of buccal bioadhesive properties of slow release tablets containing miconazole nitrate. Drug Dev Ind Pharm. 29, 321-337
16. Mutalik, S., Udupa, N. (2006). Glipizide matrix transdermal systems for diabetes mellitus: preparation, in vitro and preclinical studies. Life Sci. 79, 1568-1577
17. Najib, N., Suleiman, M. (1985). The kinetics of drug release from ethyl cellulose solid dispersions. Drug Dev Ind Pharm. 11, 2169-2181
18. Park, C.R., Munday, D.L. (2004). Evaluation of selected polysaccharide excipient in buccoadheaive tablets for sustained release of nicotine. Drug Dev In. Pharm. 30, 609-617
19. Philip, A.K., Pathak, K. (2008). Wet process-induced phase-transited drug delivery system: a means for achieving osmotic, controlled, and level a ivivc for poorly water-soluble drug. Drug Dev Ind Pharm. 34, 735-743
20. Rang, H.P., Dale, M.M., Ritter, J.M., Moore, P.K. 2005. Pharmacology, 5th ed. New Delhi: Elsevier India, 389.
21. Rowe, R.C., Sheskey, P.J., Owen, S.C. (2006). Handbook of pharmaceutical excipients. 5th ed. London: Pharmaceutical Press,112.
22. Sangeetha, S., Santhi, K., Ponnusankar, S., Nagasamy, D., Dhanraj, S.A., Suresh, B. (2007). Formulation and evaluation of buccal disks containing fluconazole. Ind Pharm. 6, 62-64
23. Satoh, K., Takayama, K., Machida, Y., Suzuki, Y., Nakagaki, M., Nagai, T. (1989). Factors affecting the bioadhesive property of tablets consisting of hydroxypropyl cellulose and caboxyvinyl polymer. Chem Pharm Bull. 37, 1366-1368
24. Varshosaz, J., Dehghan, Z. (2002). Development and characterization of buccoadhesive nifedipine tablets. Eur J Pharm Biopharm. 54, 35-141.
25. World Health Organization. 2007. WHO model list of essential medicines. 15th ed. WHO, 21. Available online at: http://www.who. int/medicines/ publications/08-English-index FINAL-EMLIS. pdf. Accessed 12 January 2009.